Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Bernstein

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsivenessShannon P Hilchey, James J Kobie, Mathew R Cochran, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2011
Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic eraSarah F Keller, Jennifer L Kelly, Elizabeth Sensenig, et al.
Blood|August 9, 2011
Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiationShannon P Hilchey, Alexander F Rosenberg, Ollivier Hyrien, et al.
Plos One|May 27, 2016
Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph NodeHristina Nedelkovska, Alexander F Rosenberg, Shannon P Hilchey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2010
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotectionGordon L Phillips, Steven H Bernstein, Jane L Liesveld, et al.
Blood|January 18, 2011
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphomaJonathan W Friedberg, Julie M Vose, Jennifer L Kelly, et al.
Blood|October 22, 2010
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cellsYohei Iwata, Takashi Matsushita, Mayuka Horikawa, et al.
Leukemia & Lymphoma|January 14, 2016
A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520Soham D Puvvada, Hongli Li, Lisa M Rimsza, et al.
British Journal of Haematology|October 23, 2015
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601Brian G Till, Hongli Li, Steven H Bernstein, et al.
American Journal of Hematology|June 2, 2011
Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host diseaseLaurie A Milner, Michael W Becker, Steven H Bernstein, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsivenessShannon P Hilchey, James J Kobie, Mathew R Cochran, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2011
Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic eraSarah F Keller, Jennifer L Kelly, Elizabeth Sensenig, et al.
Blood|August 9, 2011
Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiationShannon P Hilchey, Alexander F Rosenberg, Ollivier Hyrien, et al.
Plos One|May 27, 2016
Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph NodeHristina Nedelkovska, Alexander F Rosenberg, Shannon P Hilchey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2010
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotectionGordon L Phillips, Steven H Bernstein, Jane L Liesveld, et al.
Blood|January 18, 2011
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphomaJonathan W Friedberg, Julie M Vose, Jennifer L Kelly, et al.
Blood|October 22, 2010
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cellsYohei Iwata, Takashi Matsushita, Mayuka Horikawa, et al.
Leukemia & Lymphoma|January 14, 2016
A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520Soham D Puvvada, Hongli Li, Lisa M Rimsza, et al.
British Journal of Haematology|October 23, 2015
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601Brian G Till, Hongli Li, Steven H Bernstein, et al.
American Journal of Hematology|June 2, 2011
Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host diseaseLaurie A Milner, Michael W Becker, Steven H Bernstein, et al.
Pageof 6